🔬 Current Disease Focus:
Task Progress: 0%
👥 Active Problem Solvers
0
🌍 Experts collaborating globally
⚡ Current Task Assignment
🧬 Genetic Analysis
🔄 Matching experts to specific tasks
📊 Resource Allocation by Research Phase:
📚 Data Analysis
🧪 Experimental Design
🔬 Clinical Trials
💊 Treatment Development
A Phase 2, Randomized, Placebo-controlled, Multicenter, Masked Study to Eva...
Status
Recruiting
Location
Associated Retina Consultants (01065)
Start Date
2025-06-23
Trial ID
NCT07215390
Treatments Being Tested
The purpose of the study is to determine the efficacy of pegcetacoplan admi...
Status
Completed
Location
The Oncology Institute of Hope and Innovation
Start Date
2022-10-20
Trial ID
NCT05096403
Treatments Being Tested
Safety Assessment of Pegcetacoplan in Patients with Neovascular AMD...
Status
Terminated
Location
Apellis Clinical Site
Start Date
2018-02-14
Trial ID
NCT03465709
Treatments Being Tested
This is a phase 3, open-label study to evaluate the safety of pegcetacoplan...
Status
Completed
Location
California Retina Consultants
Start Date
2025-10-24
Trial ID
NCT07214740
Treatments Being Tested
The objectives of the study are to assess the safety, tolerability, prelimi...
Status
Completed
Location
Prince of Wales Hospital
Start Date
2015-12-01
Trial ID
NCT02588833
Treatments Being Tested
A Prospective, Multicenter, Open-Label, Observational Phase 4 Study to Eval...
Status
Active Not Recruiting
Location
California Retina Consultants (01-026)
Start Date
2023-09-28
Trial ID
NCT06161584
Treatments Being Tested
The primary objectives of the study are to assess the safety, tolerability ...
Status
Completed
Location
Retina Speciality Institute
Start Date
2015-09-24
Trial ID
NCT02503332
Treatments Being Tested
Evaluation of the Efficacy and Safety of APL-2 in Patients with Paroxysmal ...
Status
Completed
Location
University of Southern California
Start Date
2018-06-14
Trial ID
NCT03500549
Treatments Being Tested
The purpose of the study was to assess pharmacokinetics (PK), pharmacodynam...
Status
Completed
Location
City of Hope
Start Date
2022-02-01
Trial ID
NCT05148299
Treatments Being Tested
This study will be the initial exploration of pegcetacoplan in patients wit...
Status
Completed
Location
University of Southern California Norris Comprehensive Cancer Center
Start Date
2015-02-23
Trial ID
NCT02264639
Treatments Being Tested